DK541879A - Farmaceutiske praeparater indeholdende et polymert middel til frigoerelse af 5-aminosalicylsyre eller dets salte i mave og tarmkanalen - Google Patents

Farmaceutiske praeparater indeholdende et polymert middel til frigoerelse af 5-aminosalicylsyre eller dets salte i mave og tarmkanalen

Info

Publication number: DK541879A
Authority: DK; Denmark
Prior art keywords: mave; salts; release; gas; pharmaceutical preparations
Prior art date: 1978-12-20

Application number

DK541879A

Other languages

Danish (da)

English (en)

Inventor

T M Parkinson

J P Brown

R E Wingard

Original Assignee

Dynapol Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-12-20

Filing date

1979-12-19

Publication date

1980-06-21

1978-12-20 Priority claimed from US05/971,609 external-priority patent/US4190716A/en

1979-12-19 Application filed by Dynapol Corp filed Critical Dynapol Corp

1980-06-21 Publication of DK541879A publication Critical patent/DK541879A/da

Links

239000003795 chemical substances by application Substances 0.000 title 1
KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 title 1
229960004963 mesalazine Drugs 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G85/00—General processes for preparing compounds provided for in this subclass
- C08G85/004—Modification of polymers by chemical after-treatment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/34—Introducing sulfur atoms or sulfur-containing groups
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
- C08G65/48—Polymers modified by chemical after-treatment

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

DK541879A 1978-12-20 1979-12-19 Farmaceutiske praeparater indeholdende et polymert middel til frigoerelse af 5-aminosalicylsyre eller dets salte i mave og tarmkanalen DK541879A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US05/971,609 US4190716A (en)	1978-12-20	1978-12-20	Polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
US06/095,411 US4298595A (en)	1978-12-20	1979-11-29	Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract

Publications (1)

Publication Number	Publication Date
DK541879A true DK541879A (da)	1980-06-21

Family

ID=26790195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK541879A DK541879A (da)	1978-12-20	1979-12-19	Farmaceutiske praeparater indeholdende et polymert middel til frigoerelse af 5-aminosalicylsyre eller dets salte i mave og tarmkanalen

Country Status (16)

Country	Link
US (1)	US4298595A (fr)
EP (1)	EP0013000B1 (fr)
AT (1)	AT366068B (fr)
AU (1)	AU535100B2 (fr)
CA (1)	CA1130281A (fr)
DE (1)	DE2966737D1 (fr)
DK (1)	DK541879A (fr)
ES (1)	ES8101630A1 (fr)
FI (1)	FI793991A7 (fr)
GR (1)	GR68718B (fr)
IL (1)	IL58969A (fr)
IT (1)	IT1162426B (fr)
MC (1)	MC1302A1 (fr)
NO (1)	NO794171L (fr)
NZ (1)	NZ192458A (fr)
PT (1)	PT70615A (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57500432A (fr) *	1980-03-20	1982-03-11
US4960765A (en) *	1980-03-20	1990-10-02	Farmaceutisk Laboratorium Ferring A/S	Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
WO1984004041A1 (fr) *	1983-04-14	1984-10-25	Univ California	Systeme d'administration de medicaments specifiques du colon
GB8401166D0 (en) *	1984-01-17	1984-02-22	Bevaloid Ltd	Labelled polymer compositions
US5032572A (en) *	1984-07-18	1991-07-16	Medical College Of Ohio	Polymers containing cross-linked azo bonds, which polymers are useful for releasing therapeutic agents into the lower gastrointestinal tract
US4663308A (en) *	1984-07-18	1987-05-05	Medical College Of Ohio	Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
US5484605A (en) *	1988-11-25	1996-01-16	Henning Berlin Gmbh Chemie-Und Pharmawerk	Agent for treating chronically inflammatory intestinal diseases
BE1003677A3 (nl) *	1990-01-29	1992-05-19	Schacht Etienne	Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
US5120306A (en) *	1990-03-21	1992-06-09	Gosselin Leon F	Direct delivery of anti-inflammatories to the proximal small bowel
US5405919A (en) *	1992-08-24	1995-04-11	The United States Of America As Represented By The Secretary Of Health And Human Services	Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6486214B1 (en) *	1997-09-10	2002-11-26	Rutgers, The State University Of New Jersey	Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
US7122615B1 (en) *	1998-09-10	2006-10-17	Rutgers, The State University Of New Jersey	Polyanhydrides with therapeutically useful degradation products
US6468519B1 (en) *	1997-09-10	2002-10-22	Rutgers, The State University Of New Jersey	Polyanhydrides with biologically active degradation products
DE19813613A1 (de)	1998-03-27	1999-09-30	Jochen Kerres	Modifiziertes Polymer und modifizierte Polymermembran
US20040038948A1 (en) *	1999-12-07	2004-02-26	Uhrich Kathryn E.	Therapeutic compositions and methods
AU2001279064A1 (en) *	2000-07-27	2002-02-13	Rutgers, The State University	Therapeutic azo-compounds for drug delivery
DK1313697T3 (da)	2000-08-29	2006-04-10	Nobex Corp	Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
US8048924B2 (en)	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
WO2004006863A2 (fr) *	2002-07-17	2004-01-22	Rutgers, The State University	Dispositifs therapeutiques pour croissance cellulaire structuree
JP2007520495A (ja)	2004-02-06	2007-07-26	ボロディートーマスユリウス	下痢型過敏性腸症候群におけるアミノサリチル酸の使用法
US20080306029A1 (en) *	2004-05-28	2008-12-11	Salix Pharmaceuticals, Inc.	Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
DK1773767T3 (en)	2004-07-07	2016-03-21	Biocon Ltd	Synthesis of azo bound in immune regulatory relations
US7452872B2 (en)	2005-08-24	2008-11-18	Salix Pharmaceuticals, Inc.	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) *	2006-11-03	2014-12-30	Salix Pharmaceuticals, Inc.	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
EP2529729A1 (fr) *	2005-08-24	2012-12-05	Salix Pharmaceuticals, Inc.	Préparations de balsalazide et leur fabrication
WO2008033124A1 (fr) *	2006-09-13	2008-03-20	The Procter & Gamble Company	Procédé de traitement d'une rectocolite hémorragique
WO2008034019A2 (fr)	2006-09-13	2008-03-20	Polymerix Corporation	Agents actifs et oligomères et polymères de ceux-ci
US20100048519A1 (en) *	2006-09-13	2010-02-25	Chyon-Hwa Yeh	Methods of treatment for ulcerative colitis using aminosalicylate
US8436051B2 (en) *	2007-06-08	2013-05-07	Aptalis Pharma Canada Inc.	Mesalamine suppository
US7541384B2 (en)	2007-06-08	2009-06-02	Axcan Pharma Inc.	Mesalamine suppository
US8217083B2 (en) *	2007-06-08	2012-07-10	Aptalis Pharma Canada Inc.	Mesalamine suppository
JP2013525440A (ja)	2010-04-26	2013-06-20	サリックスファーマシューティカルズリミテッド	男性の治療のための２−ヒドロキシ−５−フェニルアゾ安息香酸誘導体の製剤および使用
US8741317B2 (en)	2010-08-19	2014-06-03	Rutgers, The State University Of New Jersey	Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
US9144579B2 (en)	2012-08-17	2015-09-29	Rutgers, The State University Of New Jersey	Polyesters and methods of use thereof
US20140120057A1 (en)	2012-10-25	2014-05-01	Rutgers, The State University Of New Jersey	Polymers and methods thereof for wound healing
US9387250B2 (en)	2013-03-15	2016-07-12	Rutgers, The State University Of New Jersey	Therapeutic compositions for bone repair
WO2014194055A1 (fr)	2013-05-29	2014-12-04	Rutgers, The State University Of New Jersey	Poly(anhydride-esters) à base d'antioxydants
US10023521B2 (en)	2014-06-13	2018-07-17	Rutgers, The State University Of New Jersey	Process and intermediates for preparing poly(anhydride-esters)
WO2016164898A1 (fr)	2015-04-10	2016-10-13	Rutgers, The State University Of New Jersey	Polymères d'acide kojique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3862312A (en) *	1968-01-08	1975-01-21	Ici Ltd	Compositions comprising a resinate of dl- or l-tetramisole, and treatment therewith
US3920855A (en) *	1973-11-30	1975-11-18	Dynapol Corp	Food containing non-toxic food coloring compositions and a process therefor
US4096134A (en) *	1975-12-08	1978-06-20	Dynapol	Ethylsulfonate-alkylamine copolymers as colorant backbones

1979
- 1979-11-29 US US06/095,411 patent/US4298595A/en not_active Expired - Lifetime
- 1979-12-17 IL IL58969A patent/IL58969A/xx unknown
- 1979-12-18 IT IT51122/79A patent/IT1162426B/it active
- 1979-12-19 NO NO794171A patent/NO794171L/no unknown
- 1979-12-19 MC MC791420A patent/MC1302A1/fr unknown
- 1979-12-19 NZ NZ192458A patent/NZ192458A/en unknown
- 1979-12-19 PT PT70615A patent/PT70615A/pt unknown
- 1979-12-19 FI FI793991A patent/FI793991A7/fi not_active Application Discontinuation
- 1979-12-19 EP EP79105279A patent/EP0013000B1/fr not_active Expired
- 1979-12-19 AT AT0802479A patent/AT366068B/de not_active IP Right Cessation
- 1979-12-19 CA CA342,291A patent/CA1130281A/fr not_active Expired
- 1979-12-19 DK DK541879A patent/DK541879A/da not_active Application Discontinuation
- 1979-12-19 AU AU53995/79A patent/AU535100B2/en not_active Ceased
- 1979-12-19 GR GR60802A patent/GR68718B/el unknown
- 1979-12-19 ES ES487081A patent/ES8101630A1/es not_active Expired
- 1979-12-19 DE DE7979105279T patent/DE2966737D1/de not_active Expired

Also Published As

Publication number	Publication date
PT70615A (en)	1980-01-01
IT7951122A0 (it)	1979-12-18
AT366068B (de)	1982-03-10
IT1162426B (it)	1987-04-01
CA1130281A (fr)	1982-08-24
EP0013000A3 (en)	1981-01-21
FI793991A7 (fi)	1981-01-01
NO794171L (no)	1980-06-23
MC1302A1 (fr)	1980-10-03
ES487081A0 (es)	1980-12-16
IL58969A0 (en)	1980-03-31
EP0013000A2 (fr)	1980-07-09
DE2966737D1 (en)	1984-04-05
AU5399579A (en)	1980-07-10
ES8101630A1 (es)	1980-12-16
EP0013000B1 (fr)	1984-02-29
ATA802479A (de)	1981-07-15
AU535100B2 (en)	1984-03-01
GR68718B (fr)	1982-02-04
IL58969A (en)	1983-05-15
NZ192458A (en)	1984-07-06
US4298595A (en)	1981-11-03

Legal Events

Date	Code	Title	Description
1986-09-15	AHB	Application shelved due to non-payment

Publication	Publication Date	Title
DK541879A (da)	1980-06-21	Farmaceutiske praeparater indeholdende et polymert middel til frigoerelse af 5-aminosalicylsyre eller dets salte i mave og tarmkanalen
DK351984D0 (da)	1984-07-18	Farmaceutisk middel baseret paa valproinsyre og fremgangsmaade til fremstilling deraf
DK253779A (da)	1980-02-04	Insecticidt middel og fremgangsmaade til fremstilling deraf
DK164545C (da)	1992-11-30	Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK148904C (da)	1986-04-14	Analogifremgangsmaade til fremstilling af analgetisk virksomme enkephalin-analoge pentapeptidamider eller farmaceutisk acceptable, ikke-toxiske syreadditionssalte deraf
DK281777A (da)	1977-12-26	Fremgangsmade til fremstilling af 4-hydroxyphenylethylamin-forbindelser eller syreadditionssalte deraf og mellemprodukter til anvendelse ved fremgangsmaden
DK374679A (da)	1980-03-09	Fremgangsmaade til fremstilling af 7beta-aminothiazolyl-acetamido-3-cephem-4-carboxylsyreforbindelser og salte deraf
DK344779A (da)	1980-02-19	Agrokemisk middel indeholdende azulminsyre dets fremstilling og anvendelse
DK573275A (da)	1976-06-21	Substituerede propanol (2)-derivater og nikotinsyreestere deraf samt fremgangsmade til fremstilling af disse forbindelser
DK496977A (da)	1978-05-10	Fremgangsmaade til fremstilling af 0-alkylerede hydroxylaminer og syreadditionssalte deraf
DK411378A (da)	1979-03-20	Partikelmateriale til anvendelse som vaccine isaer koleravaccine dets fremstilling og anvendelse
DK359577A (da)	1978-02-15	Fremgangsmade til fremstilling af 2-phenylaminoimidazolin-(2) og syreadditionssalte
DK290080A (da)	1981-01-10	Fremgangsmaade til fremstilling af et vandigt mavesyreneutraliserende middel
DK138427B (da)	1978-09-04	Analogifremgangsmåde til fremstilling af amider af apovincamin- og desoxyvincaminsyre eller syreadditionssalte heraf.
DK421677A (da)	1978-03-25	Alkoxysubstituerede pyrimidinylthionophosphonsyreestere fremgangsmaade til deres fremstilling og deres anvendelse som insecticider og acaricider
DK209879A (da)	1979-11-24	Fremgangsmaade til fremstilling af aryleddikesyrederivater nellemprodukter hertil og disses fremstilling
DK575177A (da)	1978-06-25	Fremgangsmaade til fremstilling af sulfamoylbenzoesyrer isaer i4-stilling substituerede 3-sulfamoyl-5-pyrrolylalkylbenzoesyrer og salte deraf
DK201275A (da)	1975-11-09	Oplosninger af komplekse antimonforbindelser samt fremgangsmade til disses fremstilling og anvendelse
IT1164969B (it)	1987-04-22	Derivati della fenilurea, procedimento per la preparazione di questi composti e mezzi erbicidi che li contengono
DK333279A (da)	1980-02-11	Fremgangsmaade til fremstilling af thiosubstitituerede diazacycloalkener og salte deraf
DK453779A (da)	1980-04-28	Halogenerede estere af cyklopropansyre fremstillingen heraf produkter baseret herpaa og anvendelsen heraf som insekticider
DK52380A (da)	1980-08-09	Benzamidinderivater fremgangsmaade til fremstilling deraf og fungicider indeholdende disse
DK136646C (da)	1978-04-17	Analogifremgangsmaade til fremstilling af basisk substituerede2-carbalkoxyamino-benzimidazolyl-5(6)-phenylethere og -ketoner eller syreadditionssalte deraf
DK30679A (da)	1979-07-26	Fremgangsmaade til fremstilling af 4-aminobutsyre og dets derivater
DK326475A (da)	1976-01-20	Fremgangsmade til fremstilling af nbetasubstituerede 8-beta-aminoethylergolin-iderivater og salte deraf